Cargando…
Antibody Conjugates for Sarcoma Therapy: How Far along Are We?
Sarcomas are one of the most difficult type of cancer to manage and treat because of their extremely heterogeneous molecular and morphological features. Despite the progress made over the years in the establishment of standard protocols for high and low grading/staging sarcoma patients, mostly with...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392509/ https://www.ncbi.nlm.nih.gov/pubmed/34440182 http://dx.doi.org/10.3390/biomedicines9080978 |